Holed up at his home in the south of France, the founder of troubled breast implant manufacturer PIP is fighting back against a growing international scandal over his allegedly faulty products.

"/> Holed up at his home in the south of France, the founder of troubled breast implant manufacturer PIP is fighting back against a growing international scandal over his allegedly faulty products.

" />
SHARE
COPY LINK

HEALTH

Breast implant tycoon hits back over scandal

Holed up at his home in the south of France, the founder of troubled breast implant manufacturer PIP is fighting back against a growing international scandal over his allegedly faulty products.

Breast implant tycoon hits back over scandal
Webphotographeer (File)

Between 300,000 and 400,000 women in 65 countries from Europe to Latin America have implants made with sub-standard silicone gel by 72-year-old Jean-Claude Mas’s now-bankrupt company Poly Implant Prothese (PIP).

France last week advised 30,000 women to have their PIP implants removed because of an increased risk of rupture and Venezuela’s government announced on Tuesday that women with the implants could have them removed for free.

Authorities in other countries have advised women to consult their doctors over the implants, while it emerged on Monday that US authorities had already raised the alarm over the company in 2000.

Lawsuits filed in the US cite defective merchandise not suited for its intended purpose and violations of consumer legislation by PIP, which was once the world’s third-largest producer of silicone implants.

With Mas due in a French court next year, questions are increasingly being asked over why it took until 2010 for French authorities to intervene, while Mas’s lawyer has been actively defending his client in the press.

“He’s at home… he’s not on the run at all. Moreover he can’t walk because he’s just been operated on,” lawyer Yves Haddad told AFP on Tuesday, saying he simply “doesn’t want to talk” publicly.

Haddad said that Mas freely admits using unapproved silicon gel, but remains adamant it is safe.

“PIP knew it wasn’t in compliance, but it wasn’t a toxic product,” the lawyer said, adding it “had not been proven” the implants were any more likely to leak.

“The fact that it’s an irritant (when ruptured) is the same for all silicone gels,” Haddad said, also denying that his client had ever been a sausage butcher or wine merchant, as reported by the French press.

PIP used two types of silicone in its implants, Haddad said. One of them was an approved gel made by American firm Nusil, but it also used an “identical” homemade gel that was five times cheaper.

According to PIP’s 2010 bankruptcy filing, it had exported 84 percent of its annual production of 100,000 implants.

Prosecutors in Marseille, near PIP’s laboratory at Seyne-sur-Mer on the Mediterranean, have received more than 2,000 complaints from French women who received the implants, and are pursuing a criminal investigation.

A lawyer representing four French women who received the PIP implants, Laurent Gaudon, said Wednesday they would be suing the manufacturer and their surgeons.

Gaudon said he would file the suit next week at a court in the city of Toulon and that the four women would be suing PIP, German company TUV which provided quality certification for PIP, and their four cosmetic surgeons.

“The doctors must be questioned by experts… They could not have been ignorant of the fact that these implants were fragile,” he said, adding that his clients had discovered cracks in their implants but not yet had them removed.

On Tuesday it emerged that the US Food and Drug Administration had already in 2000 sent a letter to PIP warning of “serious” quality control violations involving its saline implants.

Although the complaint targeted saline rather than the silicone implants at the centre of the current scandal, the letter outlined a list of quality assurance problems.

The FDA warned they “may be symptomatic of serious underlying problems in your firm’s manufacturing and quality assurance systems.”

Mas worked at pharmaceutical giant Bristol-Myers (now Bristol-Myers Squibb) before meeting up with plastic surgeon Henri Arion who introduced breast implants to France in 1965, Haddad said.

Mas’s trial for “aggravated fraud” is due to open late 2012, while a manslaughter inquiry has also been opened after at least one suspicious death in France.


Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

Lengthy waiting times at Danish hospitals not going away yet: minister

Danish Minister for the Interior and Health Sophie Løhde has warned that, despite increasing activity at hospitals, it will be some time before current waiting lists are reduced.

Lengthy waiting times at Danish hospitals not going away yet: minister

The message comes as Løhde was set to meet with officials from regional health authorities on Wednesday to discuss the progress of an acute plan for the Danish health system, launched at the end of last year in an effort to reduce a backlog of waiting times which built up during the coronavirus crisis.

An agreement with regional health authorities on an “acute” spending plan to address the most serious challenges faced by the health services agreed in February, providing 2 billion kroner by the end of 2024.

READ ALSO: What exactly is wrong with the Danish health system?

The national organisation for the health authorities, Danske Regioner, said to newspaper Jyllands-Posten earlier this week that progress on clearing the waiting lists was ahead of schedule.

Some 245,300 operations were completed in the first quarter of this year, 10 percent more than in the same period in 2022 and over the agreed number.

Løhde said that the figures show measures from the acute plan are “beginning to work”.

“It’s positive but even though it suggests that the trend is going the right way, we’re far from our goal and it’s important to keep it up so that we get there,” she said.

“I certainly won’t be satisfied until waiting times are brought down,” she said.

“As long as we are in the process of doing postponed operations, we will unfortunately continue to see a further increase [in waiting times],” Løhde said.

“That’s why it’s crucial that we retain a high activity this year and in 2024,” she added.

Although the government set aside 2 billion kroner in total for the plan, the regional authorities expect the portion of that to be spent in 2023 to run out by the end of the summer. They have therefore asked for some of the 2024 spending to be brought forward.

Løhde is so far reluctant to meet that request according to Jyllands-Posten.

SHOW COMMENTS